| Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications P Jansook, N Ogawa, T Loftsson International journal of pharmaceutics 535 (1-2), 272-284, 2018 | 679 | 2018 |
| Solubility of cyclodextrins and drug/cyclodextrin complexes P Saokham, C Muankaew, P Jansook, T Loftsson Molecules 23 (5), 1161, 2018 | 552 | 2018 |
| Self-assembled cyclodextrin aggregates and nanoparticles M Messner, SV Kurkov, P Jansook, T Loftsson International journal of pharmaceutics 387 (1-2), 199-208, 2010 | 367 | 2010 |
| Cyclodextrins as solubilizers: formation of complex aggregates P Jansook, SV Kurkov, T Loftsson Journal of pharmaceutical sciences 99 (2), 719-729, 2010 | 141 | 2010 |
| Carvedilol: solubilization and cyclodextrin complexation: a technical note T Loftsson, SB Vogensen, C Desbos, P Jansook AAPs PharmSciTech 9, 425-430, 2008 | 114 | 2008 |
| Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema M Tanito, K Hara, Y Takai, Y Matsuoka, N Nishimura, P Jansook, ... Investigative ophthalmology & visual science 52 (11), 7944-7948, 2011 | 106 | 2011 |
| CDs as solubilizers: Effects of excipients and competing drugs P Jansook, T Loftsson International Journal of Pharmaceutics 379 (1), 32-40, 2009 | 98 | 2009 |
| Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations T Loftsson, HH Sigurđsson, F Konráđsdóttir, S Gísladóttir, P Jansook, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 63 (3 …, 2008 | 93 | 2008 |
| Topical drug delivery to the eye: dorzolamide T Loftsson, P Jansook, E Stefansson Acta Ophthalmologica 90 (7), 603-608, 2012 | 91 | 2012 |
| Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension P Jansook, E Stefánsson, M Thorsteinsdóttir, BB Sigurdsson, ... European journal of pharmaceutics and biopharmaceutics 76 (2), 208-214, 2010 | 89 | 2010 |
| Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes M Messner, SV Kurkov, ME Brewster, P Jansook, T Loftsson International journal of pharmaceutics 407 (1-2), 174-183, 2011 | 83 | 2011 |
| yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension P Jansook, GC Ritthidej, H Ueda, E Stefánsson, T Loftsson Journal of Pharmacy & Pharmaceutical Sciences 13 (3), 336-350, 2010 | 56 | 2010 |
| Effect of self-aggregation of γ-cyclodextrin on drug solubilization P Jansook, MD Moya-Ortega, T Loftsson Journal of Inclusion Phenomena and Macrocyclic Chemistry 68, 229-236, 2010 | 52 | 2010 |
| Cyclodextrin–poloxamer aggregates as nanocarriers in eye drop formulations: Dexamethasone and amphotericin B P Jansook, W Pichayakorn, C Muankaew, T Loftsson Drug development and industrial pharmacy 42 (9), 1446-1454, 2016 | 51 | 2016 |
| Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations S Jóhannsdóttir, P Jansook, E Stefánsson, T Loftsson International journal of pharmaceutics 493 (1-2), 86-95, 2015 | 51 | 2015 |
| Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations P Jansook, Z Fülöp, GC Ritthidej Drug development and industrial pharmacy 45 (4), 560-567, 2019 | 48 | 2019 |
| Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients C Muankaew, P Jansook, E Stefánsson, T Loftsson International journal of pharmaceutics 474 (1-2), 80-90, 2014 | 47 | 2014 |
| Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits S Johannsdottir, P Jansook, E Stefansson, IM Kristinsdottir, Z Fulop, ... Journal of Drug Delivery Science and Technology 45, 449-454, 2018 | 43 | 2018 |
| Pharmacokinetics of a new, nasal formulation of naloxone I Tylleskar, AK Skulberg, T Nilsen, S Skarra, P Jansook, O Dale European journal of clinical pharmacology 73, 555-562, 2017 | 40 | 2017 |
| Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations P Jansook, W Pichayakorn, GC Ritthidej Drug Development and Industrial Pharmacy 44 (10), 1693-1700, 2018 | 38 | 2018 |
Thorsteinn LoftssonUniversity of IcelandVerified email at hi.is
